PortfoliosLab logoPortfoliosLab logo
BRKR vs. STE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BRKR vs. STE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bruker Corporation (BRKR) and STERIS plc (STE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BRKR vs. STE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BRKR
Bruker Corporation
-23.30%-19.24%-19.99%7.82%-18.29%55.35%6.58%71.85%-12.82%62.96%
STE
STERIS plc
-13.02%24.57%-5.60%20.19%-23.43%29.47%25.50%44.09%23.66%31.73%

Fundamentals

Market Cap

BRKR:

$5.50B

STE:

$21.73B

EPS

BRKR:

-$0.06

STE:

$7.16

PS Ratio

BRKR:

1.60

STE:

3.73

PB Ratio

BRKR:

2.22

STE:

3.03

Total Revenue (TTM)

BRKR:

$3.44B

STE:

$5.83B

Gross Profit (TTM)

BRKR:

$1.60B

STE:

$2.57B

EBITDA (TTM)

BRKR:

$316.00M

STE:

$1.36B

Returns By Period

In the year-to-date period, BRKR achieves a -23.30% return, which is significantly lower than STE's -13.02% return. Over the past 10 years, BRKR has underperformed STE with an annualized return of 2.53%, while STE has yielded a comparatively higher 12.98% annualized return.


BRKR

1D
-0.11%
1M
-9.23%
YTD
-23.30%
6M
4.18%
1Y
-10.17%
3Y*
-22.64%
5Y*
-10.78%
10Y*
2.53%

STE

1D
-0.54%
1M
-11.23%
YTD
-13.02%
6M
-8.40%
1Y
-1.59%
3Y*
5.79%
5Y*
3.56%
10Y*
12.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BRKR vs. STE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRKR
BRKR Risk / Return Rank: 3131
Overall Rank
BRKR Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
BRKR Sortino Ratio Rank: 3131
Sortino Ratio Rank
BRKR Omega Ratio Rank: 3131
Omega Ratio Rank
BRKR Calmar Ratio Rank: 3131
Calmar Ratio Rank
BRKR Martin Ratio Rank: 2828
Martin Ratio Rank

STE
STE Risk / Return Rank: 3535
Overall Rank
STE Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
STE Sortino Ratio Rank: 3131
Sortino Ratio Rank
STE Omega Ratio Rank: 3131
Omega Ratio Rank
STE Calmar Ratio Rank: 3838
Calmar Ratio Rank
STE Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRKR vs. STE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bruker Corporation (BRKR) and STERIS plc (STE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BRKRSTEDifference

Sharpe ratio

Return per unit of total volatility

-0.19

-0.06

-0.13

Sortino ratio

Return per unit of downside risk

0.10

0.10

+0.01

Omega ratio

Gain probability vs. loss probability

1.01

1.01

0.00

Calmar ratio

Return relative to maximum drawdown

-0.33

-0.10

-0.23

Martin ratio

Return relative to average drawdown

-0.73

-0.29

-0.44

BRKR vs. STE - Sharpe Ratio Comparison

The current BRKR Sharpe Ratio is -0.19, which is lower than the STE Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of BRKR and STE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BRKRSTEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.19

-0.06

-0.13

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.27

0.14

-0.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.07

0.52

-0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

0.04

0.42

-0.38

Correlation

The correlation between BRKR and STE is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

BRKR vs. STE - Dividend Comparison

BRKR's dividend yield for the trailing twelve months is around 0.55%, less than STE's 1.12% yield.


TTM20252024202320222021202020192018201720162015
BRKR
Bruker Corporation
0.55%0.42%0.34%0.27%0.29%0.19%0.30%0.31%0.54%0.47%0.76%0.00%
STE
STERIS plc
1.12%0.95%1.06%0.90%0.97%0.68%0.81%0.93%1.22%1.35%1.57%1.27%

Drawdowns

BRKR vs. STE - Drawdown Comparison

The maximum BRKR drawdown since its inception was -94.83%, which is greater than STE's maximum drawdown of -77.22%. Use the drawdown chart below to compare losses from any high point for BRKR and STE.


Loading graphics...

Drawdown Indicators


BRKRSTEDifference

Max Drawdown

Largest peak-to-trough decline

-94.83%

-77.22%

-17.61%

Max Drawdown (1Y)

Largest decline over 1 year

-39.85%

-20.76%

-19.09%

Max Drawdown (5Y)

Largest decline over 5 years

-68.72%

-36.18%

-32.54%

Max Drawdown (10Y)

Largest decline over 10 years

-68.72%

-36.18%

-32.54%

Current Drawdown

Current decline from peak

-61.39%

-17.92%

-43.47%

Average Drawdown

Average peak-to-trough decline

-57.74%

-18.32%

-39.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.05%

6.89%

+11.16%

Volatility

BRKR vs. STE - Volatility Comparison

Bruker Corporation (BRKR) has a higher volatility of 13.32% compared to STERIS plc (STE) at 7.36%. This indicates that BRKR's price experiences larger fluctuations and is considered to be riskier than STE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BRKRSTEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.32%

7.36%

+5.96%

Volatility (6M)

Calculated over the trailing 6-month period

33.52%

17.81%

+15.71%

Volatility (1Y)

Calculated over the trailing 1-year period

54.34%

25.55%

+28.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.71%

25.62%

+14.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

36.73%

24.97%

+11.76%

Financials

BRKR vs. STE - Financials Comparison

This section allows you to compare key financial metrics between Bruker Corporation and STERIS plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M800.00M1.00B1.20B1.40BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
977.20M
1.50B
(BRKR) Total Revenue
(STE) Total Revenue
Values in USD except per share items

BRKR vs. STE - Profitability Comparison

The chart below illustrates the profitability comparison between Bruker Corporation and STERIS plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%42.0%44.0%46.0%48.0%50.0%52.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
47.8%
43.8%
Portfolio components
BRKR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Bruker Corporation reported a gross profit of 466.80M and revenue of 977.20M. Therefore, the gross margin over that period was 47.8%.

STE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, STERIS plc reported a gross profit of 655.50M and revenue of 1.50B. Therefore, the gross margin over that period was 43.8%.

BRKR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Bruker Corporation reported an operating income of 76.30M and revenue of 977.20M, resulting in an operating margin of 7.8%.

STE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, STERIS plc reported an operating income of 271.00M and revenue of 1.50B, resulting in an operating margin of 18.1%.

BRKR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Bruker Corporation reported a net income of 26.00M and revenue of 977.20M, resulting in a net margin of 2.7%.

STE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, STERIS plc reported a net income of 192.80M and revenue of 1.50B, resulting in a net margin of 12.9%.